You searched for viacyte - Page 5 of 7

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs

April 8, 2019 / Professor Paul Knoepfler, Ph.D. / 1 Comment

There’s nothing like stem cell good news and interesting publications to perk one up on a Monday. Enjoy. What recent papers have struck you as exciting? Novel stem cell-based cancer approaches (Part 1) It was exciting when Fate Therapeutics got the first induced pluripotent stem cell (IPSC) IND in the U.S. for their IPSC-derived natural killer cell […]

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs Read More »

20 stem cell & regenerative medicine predictions for 2019

January 2, 2019 / Professor Paul Knoepfler, Ph.D. / 6 Comments

For a long time at the end of each year, I’ve been making stem cell predictions for the coming year. Most often I’ve been making a “top 20” list of predictions and today’s post has my list for 2019. You can see how I did for 2018 here, which might have been my best year

20 stem cell & regenerative medicine predictions for 2019 Read More »

Grading my twenty 2017 stem cell predictions

December 20, 2017 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Each year I make a list of predictions for the year to come for the stem cell and regenerative medicine field. Then about a year later I grade myself on how I did as that year winds down. Here’s how I did in 2016. For 2017, late in 2016 I made 20 stem cell predictions. Let’s

Grading my twenty 2017 stem cell predictions Read More »

Stem cell good news for the holidays: biotechs, FDA, organoids

December 7, 2017 / Professor Paul Knoepfler, Ph.D.

Atsuhiro-Taguchi-and-Ryuichi-Nishinakamura-part-of-Figure-4-Cell-Stem-Cell-2017

I can see many reasons to be jolly on the regenerative medicine front as we get deeper into the holiday season as there is quite a lot of stem cell good news even if there is also some not so good news. In today’s post the focus is on the good news of late. Semma

Stem cell good news for the holidays: biotechs, FDA, organoids Read More »

Stem cell good news: Spinal Cord Injury Trial, CIRM, Grants, & More

October 2, 2017 / Professor Paul Knoepfler, Ph.D.

Stem cell good news time and more will be coming later this week. The stem cell and regenerative medicine world sometimes feels chaotic. Why? Because so much is going on both on the positive and negative sides of things. There is a whirlwind of activity and developments, and a tendency sometimes within our arena to

Stem cell good news: Spinal Cord Injury Trial, CIRM, Grants, & More Read More »

2017 stem cell predictions: score card at 1/2-way point

June 18, 2017 / Professor Paul Knoepfler, Ph.D. / 1 Comment

In December of each year I make a list of stem cell predictions for the coming year, and I made 20 such predictions for 2017 so I’m wondering how I’m doing so far on these now that it’s June. Below is my work-in-progress scorecard for these so far. Positive news from Asterias on trial for stem cell-based

2017 stem cell predictions: score card at 1/2-way point Read More »

Good stem cell news on trials, FDA, cool new papers & more

January 31, 2017 / Professor Paul Knoepfler, Ph.D. / 2 Comments

In the whirlwind that is the stem cell and regenerative medicine world, there are many concerning things that need attention, but also good stuff happens too and this post focuses on the positive. The Asterias spinal cord injury clinical trial, a phase 1/2a trial called SCiStar, continues to make encouraging news with a clean safety profile

Good stem cell news on trials, FDA, cool new papers & more Read More »

What is your favorite stem cell/regen med biotech & why?

January 20, 2017 / Professor Paul Knoepfler, Ph.D. / 8 Comments

I’m putting together a list of stem cell and regenerative medicine biotech companies for a blog post, including both public and private. I’ve got a good list already, but want it to be fairly comprehensive. I’m also curious what readers think are the most promising ones and why. So weigh in with comments please or

What is your favorite stem cell/regen med biotech & why? Read More »

Stem Cell Predictions for 2017

December 29, 2016 / Professor Paul Knoepfler, Ph.D. / 7 Comments

Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions.

Stem Cell Predictions for 2017 Read More »

Grading my stem cell predictions for 2016: how’d I do?

December 26, 2016 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions,

Grading my stem cell predictions for 2016: how’d I do? Read More »

Search Results for: viacyte